Response to dabrafenib after progression on vemurafenib in a patient with advanced BRAF V600E-mutant bronchial adenocarcinoma

Title
Response to dabrafenib after progression on vemurafenib in a patient with advanced BRAF V600E-mutant bronchial adenocarcinoma
Authors
Keywords
NSCLC, BRAF mutation, Adenocarcinoma, Lung, Resistance, Rechallenge
Journal
LUNG CANCER
Volume 87, Issue 1, Pages 85-87
Publisher
Elsevier BV
Online
2014-11-18
DOI
10.1016/j.lungcan.2014.11.008

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started